Malaysian Genomics Resource (0155) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.061x

Based on the latest financial reports, Malaysian Genomics Resource (0155) has a cash flow conversion efficiency ratio of 0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM960.00K ≈ $241.02K USD) by net assets (RM15.77 Million ≈ $3.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Malaysian Genomics Resource - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Malaysian Genomics Resource's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Malaysian Genomics Resource total liabilities for a breakdown of total debt and financial obligations.

Malaysian Genomics Resource Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Malaysian Genomics Resource ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LCK Global Kedaton JK:LCKM	0.002x
Mint Incorporation Limited Class A Ordinary Shares NASDAQ:MIMI	N/A
Alpha Modus Holdings, Inc NASDAQ:AMOD	0.090x
Titan Logix Corp. V:TLA	-0.019x
Baru Gold Corp V:BARU	-0.166x
Onelife Capital Advisors Limited NSE:ONELIFECAP	-0.637x
CLASS 1 NICKEL+TECH.LTD F:77C	0.076x
Sahathai Terminal Public Company Limited BK:PORT	0.050x

Annual Cash Flow Conversion Efficiency for Malaysian Genomics Resource (2015–2025)

The table below shows the annual cash flow conversion efficiency of Malaysian Genomics Resource from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Malaysian Genomics Resource.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	RM18.16 Million ≈ $4.56 Million	RM-744.97K ≈ $-187.04K	-0.041x	+96.33%
2024-06-30	RM22.35 Million ≈ $5.61 Million	RM-24.97 Million ≈ $-6.27 Million	-1.117x	-35.64%
2023-06-30	RM26.79 Million ≈ $6.73 Million	RM-22.07 Million ≈ $-5.54 Million	-0.824x	-53707.58%
2022-06-30	RM37.05 Million ≈ $9.30 Million	RM56.92K ≈ $14.29K	0.002x	+101.05%
2021-06-30	RM17.93 Million ≈ $4.50 Million	RM-2.64 Million ≈ $-661.90K	-0.147x	-112.93%
2020-06-30	RM10.26 Million ≈ $2.58 Million	RM11.67 Million ≈ $2.93 Million	1.137x	+2735.15%
2019-06-30	RM15.93 Million ≈ $4.00 Million	RM-687.64K ≈ $-172.64K	-0.043x	+86.54%
2018-06-30	RM19.77 Million ≈ $4.96 Million	RM-6.34 Million ≈ $-1.59 Million	-0.321x	-312.09%
2017-06-30	RM24.30 Million ≈ $6.10 Million	RM3.67 Million ≈ $922.57K	0.151x	-20.39%
2016-06-30	RM19.39 Million ≈ $4.87 Million	RM3.68 Million ≈ $924.53K	0.190x	+746.88%
2015-06-30	RM17.65 Million ≈ $4.43 Million	RM395.83K ≈ $99.38K	0.022x	--

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$9.66 Million

RM38.49 Million MYR

Market Cap Rank

#27103 Global

#856 in Malaysia

Share Price

RM0.26

Change (1 day)

-1.92%

52-Week Range

RM0.17 - RM0.26

All Time High

RM2.72